|View printer-friendly version|
|May 27, 2008 3:09 p.m.|
|Teva To Present At The UBS Global Specialty and Generic Pharmaceuticals Conference|
|Jerusalem, Israel, May 27, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the UBS Global Specialty and Generic Pharmaceuticals Conference in London. Dan Suesskind, Chief Financial Officer, and Dr. Gerard Van Odijk, President and CEO of Teva Europe, will present on Thursday, 29 May, 2008. |
What: Teva Presentation at the UBS Global Specialty and Generic Pharmaceuticals Conference in London.
Who: Dan Suesskind, Chief Financial Officer
Dr. Gerard Van Odijk, President and CEO, Teva Europe
When:Thursday, 29 May, 2008, at 11:30 a.m.
How:Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.